Clinico-experimental contribution to the antiviral action of the anticoagulant fraction of Bothrops jararaca in the treatment of chickenpox
Laterza, G.; De Serio, A.
Minerva Pediatrica 19(1): 16-18
1967
ISSN/ISBN: 0026-4946 PMID: 5628119 Document Number: 5107
L'attività terapeutica che il nuovo farmaco ha dimostrato di possedere nella varicella, se pur ci è parsa di grande interesse, non può riscuotere finora una chiara interpretazione teorica e pertanto ci proponiamo di continuare la ricerca sperimentale mentre lasciamo ai biologi il compito di una completa spiegazione dei meccanismi farmacologici.
Document emailed within 1 workday
Related Documents
Lavras, A.A.; Fichman, M.; Hiraichi, E.; Tobo, T.; Boucault, M.A. 1980: The kininases of Bothrops jararaca plasma Acta Physiologica Latino Americana 30(4): 269-274Sano-Martins, I.S.; Santoro, M.L.; Morena, P.; Sousa-e-Silva, M.C.; Tomy, S.C.; Antonio, L.C.; Nishikawa, A.K.; Gonçalves, I.L.; Larsson, M.H.; Hagiwara, M.K. 1995: Hematological changes induced by Bothrops jararaca venom in dogs Brazilian Journal of Medical and Biological Research 28(3): 303-312
Chudzinski, A.M.; Sampaio, M.U.; Oliva, M.L.; Sampaio, C.A. 1989: A Bothrops jararaca plasma cysteine-proteinase inhibitor related to mammalian kininogen Brazilian Journal of Medical and Biological Research 22(8): 945-948
Prezoto, B.C.; Hiraichi, E.; Abdalla, F.M.; Lavras, A.A.; Picarelli, Z.P. 1989: Effect of the substance(s) released in vitro by the interaction of Bothrops jararaca (BJ) venom or trypsin and BJ plasma on BJ blood pressure and uterus Advances in Experimental Medicine and Biology 247b: 419-424
Ferreira, S.H. 1994: University discoveries and intellectual property rights: from Bothrops jararaca bradykinin potentiating peptides to angiotensin converting enzyme inhibitors Brazilian Journal of Medical and Biological Research 27(8): 1693-1698
Rodríguez-Acosta, A.; Aguilar, I.; Girón, M.E. 1993: Preparación toxoide a partir de la fracción hemorrágica del veneno de Bothrops asper (serpiente de América Central y del Sur) (Toxoid preparation from hemorrhagic fraction of the venom from Bothrops asper (snake from Central and South America) Revista Cubana de Medicina Tropical 45(1): 16-19
Allegra, C.; Bonifacio, M.; Riccioni, C.; Tonelli, V. 1986: Mesoglycan and phlebopathy. A clinico-experimental contribution Minerva Medica 77(40): 1887-1892
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Gruncharov, V. 1973: Clinico-experimental study on the choleretic and cholagogic action of Bulgarian lavender oil Vutreshni Bolesti 12(3): 90-96
Wang, S.X.; Liu, J.X. 1987: Extract of Rubia yunnanensis (Franch) diels, fraction II-A. its protective action against experimental myocardial ischemia and effect on cardiac hemodynamics in dogs Journal of Traditional Chinese Medicine 7(4): 295-296
Davis, K.J.; Fritz, D.L.; Pitt, M.L.; Welkos, S.L.; Worsham, P.L.; Friedlander, A.M. 1996: Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops) Archives of Pathology and Laboratory Medicine 120(2): 156-163
Warter, J.; Storck, D.; Monath, C. 1973: Experimental contribution to the study of pancreatic polyseritis. The action of gravity and intrathoracic pressure on the distribution of effusions Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(3): 532-535
Shalimov, S.A.; Keĭsevich, L.V.; Medvetskiĭ, E.B.; Tarasiuk, B.A.; Volchenskova, I.I. 1994: Antiviral action of the macromolecular derivative of the platinum with deoxyribonucleic acid in the treatment of patient with malignant liver neoplasm Klinicheskaia Khirurgiia 8: 36-38
Burg, M.; Ostendorf, T.; Mooney, A.; Koch, K.M.; Floege, J. 1997: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 505-516
Kushch, A.A.; Galegov, G.A.; Klimova, R.R.; Kozlov, A.I.; Litvin, A.A. 2008: Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice Antibiotiki i Khimioterapiia 53(7-8): 31-34
Nenov, P.; Ribarova, F. 1978: Experimental studies of the duration of hexobarbital sleep and of the level of cytochrom P-450 and B5 in the microsomal fraction of rat liver after propoxur treatment Eksperimentalna Meditsina i Morfologiia 17(3): 118-121
Avrutskiĭ, G.I.; Allikmets, L.K.; Neduva, A.A.; Zharkovskiĭ, A.M.; Beliakov, A.V. 1984: Various methods of overcoming secondary resistance to treatment developing in relation to adaptation to psychotropic drugs during long-term treatment (clinico-experimental study) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(8): 1213-1220
Tartara, A.; Arrigo, A.; Scamoni, C.; Presazzi, A. 1973: Clinico-experimental studies in the treatment of epilepsy with GABOB-diazepam Minerva Medica 64(36): 1943-1948
Bukharovich, A.M.; Goloshchapov, N.M. 1984: Clinico-experimental substantiation of the complex treatment of patients with pyoderma using dimocifone Vestnik Dermatologii i Venerologii 68(9): 14-19
Vrána, M.; Hess, L.; Vránová, Z.; Fejfar, Z. 1987: An experimental contribution to the treatment of acute myocardial infarction Czechoslovak Medicine 10(3): 142-155